Rtw Investments, LP Corvus Pharmaceuticals, Inc. Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 2,679,479 shares of CRVS stock, worth $10.5 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
2,679,479
Previous 2,679,479
-0.0%
Holding current value
$10.5 Million
Previous $13.9 Million
38.85%
% of portfolio
0.14%
Previous 0.23%
Shares
1 transactions
Others Institutions Holding CRVS
# of Institutions
105Shares Held
36.7MCall Options Held
1.37MPut Options Held
338K-
Orbimed Advisors LLC San Diego, CA6.94MShares$27.2 Million0.69% of portfolio
-
Samlyn Capital, LLC New York, NY4.07MShares$15.9 Million0.21% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$12.8 Million10.31% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.79MShares$10.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$9.78 Million0.0% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $182M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...